MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response
Key facts
- Who runs it
- Nantes University Hospital
- Where
- France6 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 248 people, planned
- Started
- 11 Dec 2025
- Expected to end
- 11 Dec 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Cognitive remediation program, with the PRESCO® software
- Control program, with the AUDITICO® software
- Record updated
- 19 February 2026
Who can take part
- Age
- 18 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age over 18
- Diagnosis of ADHD confirmed by DIVA-5 interview following a specialized ADHD-addiction(s) consultation
- Indication for MPH treatment according to European recommendations (J. J. S. Kooij et al., 2019) and absence of contraindications (particularly cardiological)
- Presence of at least one comorbid addictive disorder (SUD and/or BA)
- Having given their consent to take part in the study
- Being affiliated to the French social security system or benefiting from such a system
Who cannot take part
- Patients who consumned psychoactive substances within 12 hours prior to their visit
- Presence of disorders of the higher functions or difficulties in reading or writing the French language making it impossible to collect data
- Person under compulsory psychiatric care
- Pregnant or breast-feeding woman
- Person deprived of liberty
- Participation in another interventional research protocol involving another psychotherapeutic or pharmacological intervention that may have an impact on clinical outcome
- Guardianship or safeguard of justice
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
MEthylphenidate in ADHD - Addiction(s) comorbidity: benefit of adding a cognitive remediation program to improve short- and medium-term therapeutic response
The 2 groups in the trial
- Cognitive remediation programTreatment being tested
The cognitive remediation program under study (experimental treatment) consists of cognitive exercises performed on computers, in 30-45 minute sessions. The cognitive exercises target the deficits commonly observed in ADHD, a fortiori when it is associated with addictive disorders (working memory, inhibitory control, cognitive flexibility, attention, planning). The proposed program will be based on a software solution for cognitive rehabilitation, developed and validated for the treatment of attention and memory disorders and neurodegenerative, neurotraumatic and neuropsychiatric pathologies (PRESCO® software, marketed by HappyNeuron).
Treatment: Cognitive remediation program, with the PRESCO® software
- Control programExisting treatment, for comparison
For the control program (comparator), we will use a software solution from the same company, but dedicated to stimulating and training auditory functions (AUDITICO® software). The advantage of this solution is that, like PRESCO®, it offers training exercises that are not aimed at re-educating cognitive functions. These include, for example, sound identification and discrimination activities. This tool can also be used by anyone, and is accessible for follow-up by the practitioner. It also offers levels of increasing difficulty, making it stimulating for users.
Treatment: Control program, with the AUDITICO® software
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Fit questions
- Built from NCT06906328, who can take part
- Publications
- Record updated
- 19 February 2026